Belpointe Asset Management’s 4D Molecular Therapeutics FDMT Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-1,671	Closed	-$37.1K	–	3768
2022 Q4	$37.1K	Buy	+1,671	New	+$37.1K	﹤0.01%	1789